// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Role Of Grade Among Glioma Patients And Risk Of Cerebrovascular Mortality A Population-based Analysis

Kai Jin - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gliomas

N/A

Higher White Blood Cell Count In The First Week After Stroke Predicts Worse Cognitive Outcomes In A Population With Smaller Ischemic Strokes

Muhith Musabbir - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

The Challenges Of Stroke Prevention Following Intracerebral Haemorrhage; A Qualitative Study Exploring Physicians’ Decision Making.

Elena Ivany - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Hydroxyzine

A Systematic Review And Meta-analysis Of Mechanical Thrombectomy In Acute Basilar Artery Stroke

ABID MALIK - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Not All Asians Are Alike Disaggregation Of Stroke Mortality Among Asian Subgroups

Ananya L Ganesh - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Intracerebral hemorrhage

N/A

Atrial Fibrillation Modifies The Effect Of Air Pollution On Ischemic Stroke

Benjamin Y Yq Tan - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

The Role Of Interleukin-1α Cytokine In Poststroke Inflammation

Eloise Lemarchand - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Ischemic stroke

Interleukin

Prune Belly Syndrome:  Long term outcomes in an adult population.

helena gresty - Society for Paediatric Urology (SPU) , 2020

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Urinary tract infections

N/A

Bladder dysfunction in Down's syndrome

Nikita Bhatt - Society for Paediatric Urology (SPU) , 2020

Therapeutic Area

Disease

Drug/Treatment

Urology

Bladder dysfunction

N/A

Characterization of gastrointestinal dysfunction in Parkinson’s by disease stage

M. Camacho - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

Levodopa

‘Top of the POPPS’ – how we set up an online support group for Partners of People with Parkinson’s.

E. Edwards - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

A facilitated self-management toolkit for people with Parkinson’s disease: A feasibility study of ‘Live Well with Parkinson’s

M. Armstrong - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

A modified Delphi panel to establish a threshold of meaningful progression on MDS-UPDRS Part III

D. Trundell - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A qualitative study exploring the treatment burden and capacity of people with Parkinson’s and their caregivers

QY. Tan - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

A systematic review of non-motor symptoms in atypical parkinsonian syndromes

P. Ananthavarathan - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A systematic review on physical health education interventions for people with Parkinson’s: content, impact and implementation considerations across Parkinson’s trajectory

L. Alushi - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

An automated AI-based framework for putamen volume measurement in MSA

M. Papoutsi - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An automated data cleaning approach to remove preparation artefacts from brain histology slide images

V. Giunchiglia - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Multiple Sclerosis

N/A

Artificial Intelligence based detection of Parkinson’s disease in Magnetic Resonance Imaging brain scans

M. Courtman - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

Assessment of novel diffusion MRI metrics of cortical microstructure in the genetic continuum of Parkinson’s disease

M. Torso - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Parkinson's disease

N/A

Copyright © 2026. QuantiNova All rights reserved